Pharmacokinetics and tissue concentrations of cefuroxime
- PMID: 2075076
- DOI: 10.1007/BF01967830
Pharmacokinetics and tissue concentrations of cefuroxime
Abstract
Cefuroxime is well-absorbed and distributed over the human body. This review gives a general summary of published information on tissue concentrations of cefuroxime after an intravenous or intramuscular dose of 750 or 1,500 mg of cefuroxime. Tissue concentrations are given for blister fluid, meninges, eyes, respiratory tract, sputum and bronchi, abdominal and urogenital tract, uterine, ovarian and fallopian tube tissue, myometrium, membranes, placenta, puruloid and healthy human milk, bile, prostate, hip and knee bone. Pharmacokinetics are reviewed in patients with impaired kidney function and in pregnancy.
Similar articles
-
Pharmacokinetics of cefuroxime in pregnant patients with preterm premature rupture of the membranes.Pharm Weekbl Sci. 1990 Dec 14;12(6A):275-9. doi: 10.1007/BF01967832. Pharm Weekbl Sci. 1990. PMID: 2075078 Clinical Trial.
-
Determination of serum and bone concentrations of cephradine and cefuroxime by HPLC in patients undergoing hip and knee joint replacement surgery.J Antimicrob Chemother. 1989 Jun;23(6):877-83. doi: 10.1093/jac/23.6.877. J Antimicrob Chemother. 1989. PMID: 2759931
-
Bone and wound fluid concentrations of cephalosporins. Oral cefadroxil and parenteral cefuroxime compared in 52 patients with a trochanteric fracture.Acta Orthop Scand. 1995 Apr;66(2):161-5. doi: 10.3109/17453679508995513. Acta Orthop Scand. 1995. PMID: 7740949 Clinical Trial.
-
Cefuroxime: mechanisms of action, antimicrobial activity, pharmacokinetics, clinical applications, adverse reactions and therapeutic indications.Pharmacotherapy. 1983 Mar-Apr;3(2 Pt 1):82-100. Pharmacotherapy. 1983. PMID: 6344037 Review.
-
Cefuroxime axetil: an updated review of its use in the management of bacterial infections.Drugs. 2001;61(10):1455-500. doi: 10.2165/00003495-200161100-00008. Drugs. 2001. PMID: 11558834 Review.
Cited by
-
Infected cat-bite wound treated successfully with moxifloxacin after failure of parenteral cefuroxime and ciprofloxacin.Eur J Clin Microbiol Infect Dis. 2005 Apr;24(4):288-90. doi: 10.1007/s10096-005-1308-8. Eur J Clin Microbiol Infect Dis. 2005. PMID: 15902538 No abstract available.
-
Effect of Inappropriate Treatment in Hospitalized Patients with Pyelonephritis Treated with Cefuroxime: A Cohort Study.Antibiotics (Basel). 2024 Mar 19;13(3):274. doi: 10.3390/antibiotics13030274. Antibiotics (Basel). 2024. PMID: 38534709 Free PMC article.
-
Individualized antibiotic dosage regimens for patients with augmented renal clearance.Front Pharmacol. 2023 Jul 26;14:1137975. doi: 10.3389/fphar.2023.1137975. eCollection 2023. Front Pharmacol. 2023. PMID: 37564179 Free PMC article. Review.
-
Physiologically based pharmacokinetic evaluation of cefuroxime in perioperative antibiotic prophylaxis.Br J Clin Pharmacol. 2019 Dec;85(12):2864-2877. doi: 10.1111/bcp.14121. Epub 2019 Dec 15. Br J Clin Pharmacol. 2019. PMID: 31487057 Free PMC article.